F528, a novel anti-inflammation agent with the potential to modify the progression of chronic obstructive pulmonary disease ("COPD”), is undergoing preclinical studies as a potential first-line ...

This month we will look at what the liver does, how to keep it healthy, and problems that happen when the liver becomes ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

St. David's Medical Center has become the first hospital in Central Texas to offer histotripsy, a new noninvasive treatment for liver cancer.

Explore the promising potential of Altimmune, Inc.'s Pemvidutide in NASH, AUD, & obesity treatment, with key trials underway.

Hepatitis B virus infection remains one of the leading causes of liver disease, including cirrhosis and hepatocellular carcinoma.

But now scientific research conducted by Britsuperstore has revealed the secret to avoiding a hangover - green tea. Green tea contains "powerful" antioxidants called catechins which help accelerate ...

When a critical care physician suddenly needs critical care, she learns as a patient everything she wishes she’d been taught as a doctor.

Discover the causes behind fatty liver disease, a condition affecting 25% of adults worldwide, and learn simple lifestyle ...

FibroScan overestimated advanced fibrosis and cirrhosis in patients with class 3 obesity and metabolic dysfunction-associated steatotic liver disease.

A research team has made further progress in the treatment of intestinal inflammation. A study shows that the semi-synthetic bile acid NorUDCA inhibits in the intestine the formation of ...